Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit

Renal Failure

Volumn 30, Issue 9, 2008, Pages 890-895

  Frausova, Doubravka ^a,b   Brejnikova, Martina ^a,b   Hruskova, Zdenka ^a,b   Rihova, Zuzana ^a,b   Tesar, Vladimir ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ANCA; Intensive care; Mortality; Outcome; Systemic vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; APACHE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SEPTIC SHOCK; VASCULITIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHURG-STRAUSS SYNDROME; COHORT STUDIES; FEMALE; HEALTH STATUS INDICATORS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE; KIDNEY DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 54249092810     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802353892     Document Type: Article

References (22)

1. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314-322.
2. Wong DT, Knaus WA. Predicting outcome in critical care: The current status of the APACHE prognostic scoring system. Can J Anaesth. 1991;38:374-383.
3. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-2963.
4. Lemeshow S, Teres D, Klar J, Avrunin JS, Gehlbach SH, Rapoport J. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA. 1993;270:2478-2486.
5. Vincent JL, Moreno R, Takala J, et al., for the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707-710.
6. Janssen NM, Karnad DR, Guntupalli KK. Rheumatologic diseases in the intensive care unit: Epidemiology, clinical approach, management, and outcome. Crit Care Clin. 2002;18:729-748.
7. Khan SA, Subla MR, Behl D, Specks U, Afessa B. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest. 2007;131:972-976.
8. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides - proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.
9. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-1100.
10. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101-1107.
11. European Vasculitis Study Group (EUVAS): Birmingham Vasculitis Activity Score 2003 (BVAS2003). http://www.vasculitis.org/scoring/BVAS%202003.pdf. Accessed April 2008.
12. European Vasculitis Study Group (EUVAS): CYCLOPS protocol. http://www.vasculitis.org/protocols/CYCLOPS.pdf. Accessed April 2008.
13. Cruz BA, Ramanoelina J, Mahr A, et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology. 2003;42: 1183-1188.
14. Semple D, Keogh J, Forni L, Venn R. Clinical review: Vasculitis on the intensive care unit, part 2: Treatment and prognosis. Crit Care. 2005;9:193-197.
15. Kollef MH, Enzenauer RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol. 1992;19:1260-1262.
16. Raffin TA. Intensive care unit survival of patients with systemic illness. Am Rev Respir Dis. 1989;140:S28-S35.
17. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century - a disease of older patients. Rheumatology. 2005;44:495-501.
18. Rihova Z, Jancova E, Merta M, et al. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement. Kidney Blood Press Res. 2005;28:144-152.
19. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39 (Suppl. 2):S1-S246.
20. Booth AD, Almond MK, Burns A, et al.; Pan-Thames Renal Research Group. Outcome of ANCA-associated renal vasculitis: A five-year retrospective study. Am J Kidney Dis. 2003;41:776-784.
21. Jayne D, Rasmussen N, Andrassy K, et al.; European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44.
22. Godeau B, Mortier E, Roy PM, et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: A prognostic study of 181 patients. J Rheumatol. 1997;24:1317-1323.